Krsnaa Diagnostics files FY26 BRSR report detailing ESG metrics

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Krsnaa Diagnostics filed its FY26 BRSR report on September 5, 2026
  • Total energy consumption rose to 42,999 GJ from 41,362 GJ in FY25
  • Water withdrawal increased to 63,245 kilolitres, up from 37,727 kilolitres
  • Related party sales grew to 8.47% of total turnover, up from 6.13%
  • Employee well-being spending fell to 0.35% of revenue from 0.47%
powered bylight_fuzz_icon
50169051

*this image is generated using AI for illustrative purposes only.

Krsnaa Diagnostics has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, to the Bombay Stock Exchange and National Stock Exchange. The filing, dated September 5, 2026, discloses the company's environmental, social, and governance performance across its standalone operations.

The report highlights that the company operates 337 laboratories and 6,277 patient collection centers across 18 states. It details total revenue from operations of ₹6,909.47 crore and a net worth of ₹9,919.11 crore as per the CSR disclosures within the document.

Operational Footprint

As of March 31, 2026, Krsnaa Diagnostics maintained a workforce of 6,040 employees, comprising 3,296 permanent and 2,744 non-permanent staff. The gender distribution shows 53.16% male and 46.85% female employees among permanent staff. The company reported a turnover rate of 30.53% for permanent employees in FY26, up from 29.15% in FY25.

Environmental Metrics

The company reported a total energy consumption of 42,999 GJ in FY26, an increase from 41,362 GJ in the previous year. Non-renewable sources accounted for 42,767 GJ of this consumption. Greenhouse gas emissions (Scope 1 and Scope 2) totaled 261.35 tCO2e, compared to 182.65 tCO2e in FY25.

Metric FY26 FY25
Total Energy Consumption (GJ) 42,999 41,362
Total GHG Emissions (tCO2e) 261.35 182.65
Water Withdrawal (Kilolitres) 63,245 37,727
Total Waste Generated (Tonnes) 92.5 109.63

Water withdrawal increased significantly to 63,245 kilolitres from 37,727 kilolitres in FY25, sourced entirely from third-party suppliers. Total waste generated decreased to 92.5 tonnes, primarily driven by a sharp reduction in battery waste from 20.00 tonnes in FY25 to 2.37 tonnes in FY26. Biomedical waste remained stable at 87.68 tonnes.

Social Governance

The company spent ₹23.92 crore on employee well-being measures, representing 0.35% of total revenue, down from 0.47% in FY25. It reported zero fatalities and zero lost-time injuries during the year. The board includes one female director, constituting 33.33% of the total board strength.

What the Numbers Show

Related party sales accounted for 8.47% of total turnover in FY26, rising from 6.13% in FY25. This indicates a growing concentration of revenue within the group structure, with related party sales reaching ₹585.18 crore against a total turnover of ₹6,909.47 crore.

Historical Stock Returns for Krsnaa Diagnostics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.91%-0.93%-1.63%+6.64%-26.68%-28.04%

How might the 43% year-over-year increase in greenhouse gas emissions impact Krsnaa Diagnostics' ESG ratings and investor appeal in a tightening regulatory environment?

What specific strategies is management implementing to address the rising employee turnover rate of 30.53% amidst expansion across 18 states?

Could the significant jump in water withdrawal (67% YoY) signal supply chain vulnerabilities or increased operational costs due to reliance on third-party suppliers?

Krsnaa Diagnostics issues postal ballot corrigendum for preferential issue

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Corrigendum issued for preferential issue of 16,21,000 share warrants
  • Promoter group stake rises from 27.11% to 29.70% post-issue
  • No open offer required under SEBI SAST Regulations
  • E-voting concludes on September 17, 2026, at 5:00 pm
  • Control and board composition remain unchanged
powered bylight_fuzz_icon
49459235

*this image is generated using AI for illustrative purposes only.

Krsnaa Diagnostics issued a corrigendum to its postal ballot notice on August 28, 2026, following requests from the National Stock Exchange of India Limited for additional clarity. The company is seeking shareholder approval for a preferential issue of share warrants.

The original notice was dispatched on August 18, 2026, in compliance with the Companies Act, 2013, and SEBI regulations. The NSE directed the amendment via letters dated August 24, 2026, requiring specific disclosures regarding the proposed transaction.

Shareholding Changes

The corrigendum details the impact of the preferential issue on the promoter group's stake. The promoters intend to subscribe to 16,21,000 equity shares post-conversion of warrants. This acquisition will increase their aggregate holding from 27.11% to 29.70% on a fully diluted basis.

Category Pre-Issue Holding % Post-Issue Holding %
Promoter and Promoter Group 27.11 29.70

The increase falls within the limits permitted under Regulation 3(2) of the SEBI SAST Regulations for creeping acquisitions. Consequently, no open offer obligation is triggered under Regulation 10.

Allottee Details

Two entities within the promoter group have confirmed their intention to subscribe:

  • Mr. Rajendra Khivraj Mutha: 75,000 warrants
  • Krsna Diagnostics (Mumbai) Private Limited: 15,46,000 warrants

No other directors, key managerial personnel, or senior management members intend to participate in the issue. The transaction will not result in any change in control or composition of the Board of Directors.

Voting Process

Remote e-voting commenced on August 19, 2026, and concludes on September 17, 2026, at 5:00 pm. Shareholders who voted prior to receiving this corrigendum may modify their votes by emailing the scrutinizer at csdineshbirla@gmail.com with a copy to cs@krsnaa.in before the deadline.

What the Numbers Show

The preferential issue is entirely internal, with all new capital coming from existing promoter entities. Mr. Rajendra Mutha’s direct holding decreases slightly from 24.75% to 23.11%, while his indirect holding through Krsna Diagnostics (Mumbai) Private Limited rises significantly from 2.36% to 6.59%. This shift consolidates promoter control without diluting public or institutional investors, whose stakes remain unchanged in absolute numbers but decrease proportionally due to the expanded share base.

Historical Stock Returns for Krsnaa Diagnostics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.91%-0.93%-1.63%+6.64%-26.68%-28.04%

How will the capital raised from this preferential issue be allocated, and what specific growth initiatives or debt reduction strategies does Krsnaa Diagnostics plan to prioritize?

Given the consolidation of promoter holdings, how might institutional investors react to the increased promoter control in terms of future voting dynamics and corporate governance oversight?

Will the increased promoter stake provide sufficient financial stability to accelerate Krsnaa Diagnostics' expansion plans in tier-2 and tier-3 cities amid rising competition?

More News on Krsnaa Diagnostics

1 Year Returns:-26.68%